Skip to content
10-Q

Quarterly Report

LifeStance Health Group, Inc. LFST

0001193125-26-211814

← back to feed
Filed
May 7, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 29, 2026 387.83M sh
Shares Diluted Q1 2026 · Mar 31, 2026 395.08M sh
Shares Diluted Q1 2026 · Mar 31, 2025 390.67M sh
Stock Repurchased Q1 2026 · Mar 31, 2026 $49.11M
Stock Repurchased Q1 2026 · Mar 31, 2025 $0
Capex Q1 2026 · Mar 31, 2026 $10.77M
Capex Q1 2026 · Mar 31, 2025 $7.17M
Operating Cash Flow Q1 2026 · Mar 31, 2026 $33.11M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$3.09M
Long Term Debt Q1 2026 · Mar 31, 2026 $262.46M
Long Term Debt Q1 2026 · Dec 31, 2025 $265.93M
Short Term Debt Q1 2026 · Mar 31, 2026 $18.13M
Short Term Debt Q1 2026 · Dec 31, 2025 $14.5M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $194.8M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $248.64M
Stockholders Equity Q1 2026 · Mar 31, 2026 $1.48B
Stockholders Equity Q1 2026 · Dec 31, 2025 $1.52B
Current Liabilities Q1 2026 · Mar 31, 2026 $239.73M
Current Liabilities Q1 2026 · Dec 31, 2025 $251.96M
Total Liabilities Q1 2026 · Mar 31, 2026 $668.47M
Total Liabilities Q1 2026 · Dec 31, 2025 $682.92M
Current Assets Q1 2026 · Mar 31, 2026 $355.91M
Current Assets Q1 2026 · Dec 31, 2025 $416.2M
Total Assets Q1 2026 · Mar 31, 2026 $2.15B
Total Assets Q1 2026 · Dec 31, 2025 $2.2B
Sga Expense Q1 2026 · Mar 31, 2026 $100.33M
Sga Expense Q1 2026 · Mar 31, 2025 $94.43M
Net Income Q1 2026 · Mar 31, 2026 $14.24M
Net Income Q1 2026 · Mar 31, 2025 $709K
Net Income Q1 2026 · Sep 30, 2024 $709K
Operating Income Q1 2026 · Mar 31, 2026 $22.28M
Operating Income Q1 2026 · Mar 31, 2025 $1.6M